Inpatient diabetes management.
diabetes
discharge
hospitalized
inpatient
insulin dosing
Journal
Annals of the New York Academy of Sciences
ISSN: 1749-6632
Titre abrégé: Ann N Y Acad Sci
Pays: United States
ID NLM: 7506858
Informations de publication
Date de publication:
25 Jul 2024
25 Jul 2024
Historique:
medline:
26
7
2024
pubmed:
26
7
2024
entrez:
25
7
2024
Statut:
aheadofprint
Résumé
Diabetes mellitus is currently approaching epidemic proportions and disproportionately affects patients in the hospital setting. In the United States, individuals living with diabetes represent over 17 million emergency department visits and 8 million admissions annually. The management of these patients in the hospital setting is complex and differs considerably from the outpatient setting. All patients with hyperglycemia should be screened for diabetes, as in-hospital hyperglycemia portends a greater risk for morbidity, mortality, admission to an intensive care unit, and increased hospital length of stay. However, the definition of hyperglycemia, glycemic targets, and strategies to manage hyperglycemia in the inpatient setting can vary greatly depending on the population considered. Moreover, the presenting illness, changing nutritional status, and concurrent hospital medications often necessitate thoughtful consideration to adjustments of home diabetes regimens and/or the initiation of new insulin doses. This review article will examine core concepts and emerging new literature surrounding inpatient diabetes management, including glycemic targets, insulin dosing strategies, noninsulin medications, new diabetes technologies, inpatient diabetes management teams, and discharge planning strategies, to optimize patient safety and satisfaction, clinical outcomes, and even hospital financial health.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The New York Academy of Sciences.
Références
CDC. (2023). National Diabetes Statistics Report. https://www.cdc.gov/diabetes/data/statistics‐report/index.html
Zhang, Y., Bullard, K. M., Imperatore, G., Holliday, C. S., & Benoit, S. R. (2022). Proportions and trends of adult hospitalizations with diabetes, United States, 2000–2018. Diabetes Research and Clinical Practice, 187, 109862. https://doi.org/10.1016/j.diabres.2022.109862
American Diabetes Association. (2013). Economic costs of diabetes in the U.S. in 2012. Diabetes Care, 36, 1033–1046. https://doi.org/10.2337/dc12‐2625
Valent, F., Tonutti, L., & Grimaldi, F. (2017). Does diabetes mellitus comorbidity affect in‐hospital mortality and length of stay? Analysis of administrative data in an Italian Academic Hospital. Acta Diabetologica, 54, 1081–1090. https://doi.org/10.1007/s00592‐017‐1050‐6
Holman, N., Hillson, R., & Young, R. J. (2013). Excess mortality during hospital stays among patients with recorded diabetes compared with those without diabetes. Diabetic Medicine, 30, 1393–1402. https://doi.org/10.1111/dme.12282
Khan, S. A., Shields, S., Abusamaan, M. S., & Mathioudakis, N. (2022). Association between dysglycemia and the Charlson Comorbidity Index among hospitalized patients with diabetes. Journal of Diabetes and Its Complications, 36, 108305. https://doi.org/10.1016/j.jdiacomp.2022.108305
Rubin, D. J. (2015). Hospital readmission of patients with diabetes. Current Diabetes Reports, 15, 17. https://doi.org/10.1007/s11892‐015‐0584‐7
Palmer, B. F., & Clegg, D. J. (2015). Electrolyte and acid–base disturbances in patients with diabetes mellitus. New England Journal of Medicine, 373, 548–559. https://doi.org/10.1056/NEJMra1503102
American Diabetes Association Professional Practice Committee. (2024). 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024. Diabetes Care, 47, S111–S125. https://doi.org/10.2337/dc24‐S006
American Diabetes Association Professional Practice Committee. (2023). 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2024. Diabetes Care, 47, S295–S306. https://doi.org/10.2337/dc24‐S016
Pieralli, F., Bazzini, C., Fabbri, A., Casati, C., Crociani, A., Corradi, F., Pignone, A. M., Morettini, A., & Nozzoli, C. (2016). The classification of hospitalized patients with hyperglycemia and its implication on outcome: Results from a prospective observational study in Internal Medicine. Internal and Emergency Medicine, 11, 649–656. https://doi.org/10.1007/s11739‐015‐1358‐6
Barmanray, R. D., Cheuk, N., Fourlanos, S., Greenberg, P. B., Colman, P. G., & Worth, L. J. (2022). In‐hospital hyperglycemia but not diabetes mellitus alone is associated with increased in‐hospital mortality in community‐acquired pneumonia (CAP): A systematic review and meta‐analysis of observational studies prior to COVID‐19. BMJ Open Diabetes & Research Care, 10, e002880. https://doi.org/10.1136/bmjdrc‐2022‐002880
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000). Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet, 355, 773–778. https://doi.org/10.1016/S0140‐6736(99)08415‐9
Gorelik, Y., Bloch‐Isenberg, N., Hashoul, S., Heyman, S. N., & Khamaisi, M. (2021). Hyperglycemia on admission predicts acute kidney failure and renal functional recovery among inpatients. Journal of Clinical Medicine, 11, 54. https://doi.org/10.3390/jcm11010054
Frisch, A., Chandra, P., Smiley, D., Peng, L., Rizzo, M., Gatcliffe, C., Hudson, M., Mendoza, J., Johnson, R., Lin, E., & Umpierrez, G. E. (2010). Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care, 33, 1783–1788. https://doi.org/10.2337/dc10‐0304
Kotagal, M., Symons, R. G., Hirsch, I. B., Umpierrez, G. E., Dellinger, E. P., Farrokhi, E. T., & Flum, D. R. (2015). Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Annals of Surgery, 261, 97–103. https://doi.org/10.1097/SLA.0000000000000688
Ata, A., Lee, J., Bestle, S. L., Desemone, J., & Stain, S. C. (2010). Postoperative hyperglycemia and surgical site infection in general surgery patients. Archives of Surgery, 145, 858–864. https://doi.org/10.1001/archsurg.2010.179
Kerby, J. D., Griffin, R. L., Maclennan, P., & Rue, L. W. (2012). Stress‐induced hyperglycemia, not diabetic hyperglycemia, is associated with higher mortality in trauma. Annals of Surgery, 256, 446–452. https://doi.org/10.1097/SLA.0b013e3182654549
Kosiborod, M., Inzucchi, S. E., Spertus, J. A., Wang, Y., Masoudi, F. A., Havranek, E. P., & Krumholz, H. M. (2009). Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation, 119, 1899–1907. https://doi.org/10.1161/CIRCULATIONAHA.108.821843
Mifsud, S., Schembri, E. L., & Gruppetta, M. (2018). Stress‐induced hyperglycaemia. British Journal of Hospital Medicine, 79, 634–639. https://doi.org/10.12968/hmed.2018.79.11.634
Cruz, P. (2020). Inpatient hypoglycemia: The challenge remains. Journal of Diabetes Science and Technology, 14, 560–566. https://doi.org/10.1177/1932296820918540
Saliba, L., Cook, C. H., Dungan, K. M., Porter, K., & Murphy, C. V. (2016). Medication‐induced and spontaneous hypoglycemia carry the same risk for hospital mortality in critically ill patients. Journal of Critical Care, 36, 13–17. https://doi.org/10.1016/j.jcrc.2016.06.010
Khan, S. A., & Zilbermint, M. (2022). Centers for Medicare & Medicaid Services’ hospital harm measures for severe hypoglycemia and hyperglycemia: Is your hospital ready? Diabetes Spectrum, 35, 391–397. https://doi.org/10.2337/dsi22‐0008
Brutsaert, E., Carey, M., & Zonszein, J. (2014). The clinical impact of inpatient hypoglycemia. Journal of Diabetes and Its Complications, 28, 565–572. https://doi.org/10.1016/j.jdiacomp.2014.03.002
Pasquel, F. J., Lansang, M. C., Dhatariya, K., & Umpierrez, G. E. (2021). Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes & Endocrinology, 9, 174–188. https://doi.org/10.1016/S2213‐8587(20)30381‐8
Korytkowski, M. T., Muniyappa, R., Antinori‐Lent, K., Donihi, A. C, Drincic, A., Hirsch, I., Anton, L., Mcdonnell, M., Murad, M., Nielsen, C., Pegg, C., Rushakoff, R., Santesso, N., & Umpierrez, G. E. (2022). Management of hyperglycemia in hospitalized adult patients in non‐critical care settings: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 107, 2101–2128. https://doi.org/10.1210/clinem/dgac278
Bellido, V., Freckman, G., Pérez, A., & Galindo, R. J. (2023). Accuracy and potential interferences of continuous glucose monitoring sensors in the hospital. Endocrine Practice, 29, 919–927. https://doi.org/10.1016/j.eprac.2023.06.007
Avari, P., Lumb, A., Flanagan, D., Rayman, G., Misra, S., Dhatariya, K., & Choudhary, P. (2023). Continuous glucose monitoring within hospital: A scoping review and summary of guidelines from the Joint British Diabetes Societies for Inpatient Care. Journal of Diabetes Science and Technology, 17, 611–624. https://doi.org/10.1177/19322968221137338
Galindo, R. J., Umpierrez, G. E., Rushakoff, R. J., Basu, A., Lohnes, S., Nichols, J. H., Spanakis, E. K., Espinoza, J., Palermo, N. E., Awadjie, D. G., Bak, L., Buckingham, B., Cook, C. B., Freckmann, G., Heinemann, L., Hovorka, R., Mathioudakis, N., Newman, T., O'neal, D. N., … Klonoff, D. C. (2020). Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline. Journal of Diabetes Science and Technology, 14, 1035–1064. https://doi.org/10.1177/1932296820954163
Price, C., Ditton, G., Russell, G. B., & Aloi, J. (2023). Reliability of inpatient CGM: Comparison to standard of care. Journal of Diabetes Science and Technology, 17, 329–335. https://doi.org/10.1177/19322968211062168
Umpierrez, G. (2023). Glucose control in the ICU. New England Journal of Medicine, 389, 1234–1237. https://doi.org/10.1056/NEJMe2309442
Flory, J. H., Aleman, J. O., Furst, J., & Seley, J. J. (2014). Basal insulin use in the non‐critical care setting: Is fasting hypoglycemia inevitable or preventable? Journal of Diabetes Science and Technology, 8, 427–428. https://doi.org/10.1177/1932296813520367
Van Den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006). Intensive insulin therapy in the medical ICU. New England Journal of Medicine, 354, 449–461. https://doi.org/10.1056/NEJMoa052521
Finfer, S., Chittock, D. R., Su, S. Y., Blair, D., Foster, D., Dhingra, V., Bellomo, R., Cook, D., Dodek, P., Henderson, W. R., Hébert, P. C., Heritier, S., Heyland, D. K., McArthur, C., McDonald, E., Mitchell, I., Myburgh, J. A., Norton, R., Potter, J., … Ronco, J. J. (2009). Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine, 360, 1283–1297. https://doi.org/10.1056/NEJMoa0810625
Gunst, J., Debaveye, Y., Güiza, F., Dubois, J., De Bruyn, A., Dauwe, D., De Troy, E., Casaer, M. P., De Vlieger, G., Haghedooren, R., Jacobs, B., Meyfroidt, G., Ingels, C., Muller, J., Vlasselaers, D., Desmet, L., Mebis, L., Wouters, P. J., Stessel, B., … Van Den Berghe, G. (2023). Tight blood‐glucose control without early parenteral nutrition in the ICU. New England Journal of Medicine, 389, 1180–1190. https://doi.org/10.1056/NEJMoa2304855
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., Cobelli, C., Dassau, E., Devries, J. H., Donaghue, K. C., Dovc, K., Doyle, F. J., Garg, S., Grunberger, G., Heller, S., … Phillip, M. (2019). Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care, 42, 1593–1603. https://doi.org/10.2337/dci19‐0028
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. (2018). Obstetrics and Gynecology, 131, e49–e64. https://doi.org/10.1097/AOG.0000000000002501
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013). Diabetes and pregnancy: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 98, 4227–4249. https://doi.org/10.1210/jc.2013‐2465
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. (2018). ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus. Obstetrics and Gynecology, 132, e228–e248. https://doi.org/10.1097/AOG.0000000000002960
American Diabetes Association Professional Practice Committee. (2024). 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024. Diabetes Care, 47, S282–S294. https://doi.org/10.2337/dc24‐S015
Dude, A., Niznik, C., Szmuilowicz, E., Peaceman, A., & Yee, L. (2018). Management of diabetes in the intrapartum and postpartum patient. American Journal of Perinatology, 35, 1119–1126. https://doi.org/10.1055/s‐0038‐1629903
American Diabetes Association. (2024). 13. Older Adults: Standards of Care in Diabetes—2024. Diabetes Care, 47, S244–S257. https://diabetesjournals.org/care/article/47/Supplement_1/S244/153944/13‐Older‐Adults‐Standards‐of‐Care‐in‐Diabetes‐2024
Gosmanov, A. R., & Umpierrez, G. E. (2013). Management of hyperglycemia during enteral and parenteral nutrition therapy. Current Diabetes Reports, 13, 155–162. https://doi.org/10.1007/s11892‐012‐0335‐y
Umpierrez, G., Cardona, S., Pasquel, F., Jacobs, S., Peng, L., Unigwe, M., Newton, C. A., Smiley‐Byrd, D., Vellanki, P., Halkos, M., Puskas, J. D., Guyton, R. A., & Thourani, V. H. (2015). Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO‐CABG trial. Diabetes Care, 38, 1665–1672. https://doi.org/10.2337/dc15‐0303
Lazar, H. L., Mcdonnell, M., Chipkin, S. R., Furnary, A. P., Engelman, R. M., Sadhu, A. R., Bridges, C. R., Haan, C. K., Svedjeholm, R., Taegtmeyer, H., & Shemin, R. J. (2009). The Society of Thoracic Surgeons Practice Guideline Series: Blood glucose management during adult cardiac surgery. Annals of Thoracic Surgery, 87, 663–669. https://doi.org/10.1016/j.athoracsur.2008.11.011
Galindo, R. J., Fayfman, M., & Umpierrez, G. E. (2018). Perioperative management of hyperglycemia and diabetes in cardiac surgery patients. Endocrinology and Metabolism Clinics of North America, 47, 203–222. https://doi.org/10.1016/j.ecl.2017.10.005
Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M. (2011). Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care, 34, 256–261. https://doi.org/10.2337/dc10‐1407
Umpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007). Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care, 30, 2181–2186. https://doi.org/10.2337/dc07‐0295
Demidowich, A., Batty, K., Love, T., Miller, C., Motevalli, M., Noel, J., & Zilbermint, M. (2022). Abstract #1184571: Administering nutritional insulin postprandially in the inpatient setting is associated with improved glycemic metrics. Endocrine Practice, 28, S45. https://doi.org/10.1016/j.eprac.2022.03.119
Rubin, D. J., Rybin, D., Doros, G., & Mcdonnell, M. E. (2011). Weight‐based, insulin dose–related hypoglycemia in hospitalized patients with diabetes. Diabetes Care, 34, 1723–1728. https://doi.org/10.2337/dc10‐2434
Blonde, L., Umpierrez, G. E., Reddy, S. S., Mcgill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., Defronzo, R. A., Einhorn, D., Galindo, R. J., Gardner, T. W., Garg, R., Garvey, W. T., Hirsch, I. B., Hurley, D. L., Izuora, K., Kosiborod, M., Olson, D., Patel, S. B., … Weber, S. L. (2022). American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a diabetes mellitus comprehensive care plan‐2022 update. Endocrine Practice, 28, 923–1049. https://doi.org/10.1016/j.eprac.2022.08.002
Keca, S. M., Emmons, J. T., & Tannock, L. R. (2018). Insulin dose reductions in the inpatient setting: How much is enough? Endocrine Practice, 24, 391–394. https://doi.org/10.4158/EP‐2017‐0188
Khan, S., Golden, S. H., & Mathioudakis, N. (2017). Associations between home insulin dose adjustments and glycemic outcomes at hospital admission. Diabetes Research and Clinical Practice, 127, 51–58. https://doi.org/10.1016/j.diabres.2017.02.003
Kanbour, S., Yenokyan, G., Snyder, R. A., Abusamaan, M. S., & Mathioudakis, N. (2022). Glycemic outcomes of hospitalized patients on ambulatory Humulin‐R U‐500 insulin. Endocrine Practice, 28, 1232–1236. https://doi.org/10.1016/j.eprac.2022.09.005
Paulus, A. O., Colburn, J. A., True, M. W., Beckman, D. J., Davis, R. P., Wardian, J. L., Graybill, S. D., Folaron, I., & Lewi, J. E. (2016). Evaluation of total daily dose and glycemic control for patients taking U‐500 regular insulin admitted to the hospital. Endocrine Practice, 22, 1187–1191. https://doi.org/10.4158/EP161355.OR
Palladino, C. E., Eberly, M. E., Emmons, J. T., & Tannock, L. R. (2016). Management of U‐500 insulin users during inpatient admissions within a Veterans Affairs Medical Center. Diabetes Research and Clinical Practice, 114, 32–36. https://doi.org/10.1016/j.diabres.2016.02.004
Kedia, R., Desouza, C., Smith, L. M., & Shivaswamy, V. (2017). A retrospective review of insulin requirements in patients using U‐500 insulin hospitalized to a Veterans Affairs Hospital. Journal of Diabetes and Its Complications, 31, 874–879. https://doi.org/10.1016/j.jdiacomp.2017.02.008
American Diabetes Association Professional Practice Committee. (2023). 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024. Diabetes Care, 47, S158–S178. https://doi.org/10.2337/dc24‐S009
Maynard, G., Lee, J., Phillips, G., Fink, E., & Renvall, M. (2009). Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: Effect of structured subcutaneous insulin orders and an insulin management algorithm. Journal of Hospital Medicine, 4, 3–15. https://doi.org/10.1002/jhm.391
Mathioudakis, N., Jeun, R., Godwin, G., Perschke, A., Yalamanchi, S., Everett, E., Greene, P., Knight, A., Yuan, C., & Hill Golden, S. (2019). Development and implementation of a subcutaneous insulin clinical decision support tool for hospitalized patients. Journal of Diabetes Science and Technology, 13, 522–532. https://doi.org/10.1177/1932296818798036
Mehta, P. B., Kohn, M. A., Rov‐Ikpah, E., San Luis, C., Johnson, C., Lee, G., Koliwad, S., & Rushakoff, R. J. (2024). Novel automated self‐adjusting subcutaneous insulin algorithm improves glycemic control and physician efficiency in hospitalized patients. Journal of Diabetes Science and Technology, 18, 541–548. https://doi.org/10.1177/19322968241232673
Ullal, J., & Aloi, J. A. (2019). Subcutaneous insulin dosing calculators for inpatient glucose control. Current Diabetes Reports, 19, 120. https://doi.org/10.1007/s11892‐019‐1254‐y
Aloi, J., Bode, B. W., Ullal, J., Chidester, P., Mcfarland, R. S., Bedingfield, A. E., Mabrey, M., Booth, R., Mumpower, A., & Wallia, A. (2017). Comparison of an electronic glycemic management system versus provider‐managed subcutaneous basal bolus insulin therapy in the hospital setting. Journal of Diabetes Science and Technology, 11, 12–16. https://doi.org/10.1177/1932296816664746
Cui, L., Schroeder, P. R., & Sack, P. A. (2020). Inpatient and outpatient technologies to assist in the management of insulin dosing. Clinical Diabetes, 38, 462–473. https://doi.org/10.2337/cd20‐0054
Brady, V., Thosani, S., Zhou, S., Bassett, R., Busaidy, N. L., & Lavis, V. (2014). Safe and effective dosing of basal‐bolus insulin in patients receiving high‐dose steroids for hyper‐cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy. Diabetes Technology & Therapeutics, 16, 874–879. https://doi.org/10.1089/dia.2014.0115
Cheng, Y.‐C., Guerra, Y., Morkos, M., Tahsin, B., Onyenwenyi, C., Fogg, L., & Fogelfeld, L. (2021). Insulin management in hospitalized patients with diabetes mellitus on high‐dose glucocorticoids: Management of steroid‐exacerbated hyperglycemia. PLoS ONE, 16, e0256682. https://doi.org/10.1371/journal.pone.0256682
Spanakis, E. K., Shah, N., Malhotra, K., Kemmerer, T., Yeh, H. C., & Golden, S. H. (2014). Insulin requirements in non‐critically ill hospitalized patients with diabetes and steroid‐induced hyperglycemia. Hospital Practice, 42, 23–30. https://doi.org/10.3810/hp.2014.04.1100
Stone, A. C., Dungan, K., & Gaborcik, J. W. (2021). Insulin NPH for steroid‐induced hyperglycemia: Predictors for success. Pharmacotherapy, 41, 804–810. https://doi.org/10.1002/phar.2616
Bajaj, M. A., Zale, A. D., Morgenlander, W. R., Abusamaan, M. S., & Mathioudakis, N. (2022). Insulin dosing and glycemic outcomes among steroid‐treated hospitalized patients. Endocrine Practice, 28, 774–779. https://doi.org/10.1016/j.eprac.2022.05.002
Vennard, K. C., Selen, D. J., & Gilbert, M. P. (2018). The management of hyperglycemia in noncritically ill hospitalized patients treated with continuous enteral or parenteral nutrition. Endocrine Practice, 24, 900–906. https://doi.org/10.4158/EP‐2018‐0150
Drincic, A. T., Knezevich, J. T., & Akkireddy, P. (2017). Nutrition and hyperglycemia management in the inpatient setting (meals on demand, parenteral, or enteral nutrition). Current Diabetes Reports, 17, 59. https://doi.org/10.1007/s11892‐017‐0882‐3
Polavarapu, P., Pachigolla, S., & Drincic, A. (2022). Glycemic management of hospitalized patients receiving nutrition support. Diabetes Spectrum, 35, 427–439. https://doi.org/10.2337/dsi22‐0010
Zale, A., & Mathioudakis, N. (2022). Machine learning models for inpatient glucose prediction. Current Diabetes Reports, 22, 353–364. https://doi.org/10.1007/s11892‐022‐01477‐w
Wright, A. P., Embi, P. J., Nelson, S. D., Smith, J. C., Turchin, A., & Mize, D. E. (2024). Development and validation of inpatient hypoglycemia models centered around the insulin ordering process. Journal of Diabetes Science and Technology, 18, 423–429. https://doi.org/10.1177/19322968221119788
Nguyen, M., Jankovic, I., Kalesinskas, L., Baiocchi, M., & Chen, J. H. (2021). Machine learning for initial insulin estimation in hospitalized patients. Journal of the American Medical Informatics Association, 28, 2212–2219. https://doi.org/10.1093/jamia/ocab099
Moghissi, E. S., Korytkowski, M. T., Dinardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail‐Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009). American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care, 32, 1119–1131. https://doi.org/10.2337/dc09‐9029
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van Den Berghe, G. (2012). Management of hyperglycemia in hospitalized patients in non‐critical care setting: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 97, 16–38. https://doi.org/10.1210/jc.2011‐2098
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., & Hirsch, I. B. (2004). Management of diabetes and hyperglycemia in hospitals. Diabetes Care, 27, 553–591. https://doi.org/10.2337/diacare.27.2.553
Bishay, R. H., Meyerowitz‐Katz, G., Chandrakumar, D., Jayaballa, R., Hng, T. M., Mclean, M., Punchihewa, D., Jeyaprakash, M., Burgess, D., Riskallah, J., & Maberly, G. F. (2018). Evaluating the Diabetes‐Cardiology interface: A glimpse into the diabetes management of cardiology inpatients in western Sydney's “diabetes hotspot” and the establishment of a novel model of care. Diabetology & Metabolic Syndrome, 10, 90. https://doi.org/10.1186/s13098‐018‐0393‐7
Satpathy, S., Datta, S., & Upreti, B. (2016). Utilization study of antidiabetic agents in a teaching hospital of Sikkim and adherence to current standard treatment guidelines. Journal of Pharmacy and Bioallied Sciences, 8, 223–228. https://doi.org/10.4103/0975‐7406.175975
Waki, N., Memon, A., Khan, M. O., Faruqi, H., Masood, S., Rauf, M., Mirza, R., Zaigham, S., Asgher, F., Amjad, H., Nadeem, U., Farooq, S., Ali, H., & Sheikh, F. (2012). Current understanding of treatment and management protocol for adult diabetic in‐patients at a tertiary care hospital. Journal of the Pakistan Medical Association, 62, 520–524.
Pasquel, F. J., Fayfman, M., & Umpierrez, G. E. (2019). Debate on insulin vs non‐insulin use in the hospital setting—Is it time to revise the guidelines for the management of inpatient diabetes? Current Diabetes Reports, 19, 65. https://doi.org/10.1007/s11892‐019‐1184‐8
Kodner, C., Anderson, L., & Pohlgeers, K. (2017). Glucose management in hospitalized patients. American Family Physician, 96, 648–654.
Duan, D., Mathioudakis, N. N., & Pilla, S. J. (2024). Treatment of diabetes in hospitals with noninsulin medications is a research priority. Diabetes Care, 47, 915–917. https://doi.org/10.2337/dci23‐0094
Gracia‐Ramos, A. E., Cruz‐Dominguez, M. D. P., Madrigal‐Santillán, E. O., Rojas‐Martínez, R., Morales‐González, J. A., Morales‐González, Á., Hernández‐Espinoza, M., Vargas‐Peñafiel, J., & Tapia‐González, M. D. L. Á. (2024). Efficacy and safety of sitagliptin with basal‐plus insulin regimen versus insulin alone in non‐critically ill hospitalized patients with type 2 diabetes: SITA‐PLUS hospital trial. Journal of Diabetes and Its Complications, 38, 108742. https://doi.org/10.1016/j.jdiacomp.2024.108742
Subrahmanyan, N. A., Koshy, R. M., Jacob, K., & Pappachan, J. M. (2021). Efficacy and cardiovascular safety of DPP‐4 inhibitors. Current Drug Safety, 16, 154–164. https://doi.org/10.2174/1574886315999200819150544
O'hara, D. V., Lam, C. S. P., Mcmurray, J. J. V., Yi, T. W., Hocking, S., Dawson, J., Raichand, S., Januszewski, A. S., & Jardine, M. J. (2024). Applications of SGLT2 inhibitors beyond glycaemic control. Nature Reviews Nephrology, https://doi.org/10.1038/s41581‐024‐00836‐y
Cohen, B., Harris, Y. T., & Schulman‐Rosenbaum, R. (2024). Sodium‐glucose cotransporter 2 inhibitors should be avoided for the inpatient management of hyperglycemia. Endocrine Practice, 30, 402–408. https://doi.org/10.1016/j.eprac.2023.11.014
Blau, J. E., Tella, S. H., Taylor, S. I., & Rother, K. I. (2017). Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data. Diabetes Metabolism Research and Reviews, 33, e2924. https://doi.org/10.1002/dmrr.2924
Hamblin, P. S., Wong, R., Ekinci, E. I., Fourlanos, S., Shah, S., Jones, A. R., Hare, M. J. L., Calder, G. L., Epa, D. S., George, E. M., Giri, R., Kotowicz, M. A., Kyi, M., Lafontaine, N., Macisaac, R. J., Nolan, B. J., O'neal, D. N., Renouf, D., Varadarajan, S., … Bach, L. A. (2019). SGLT2 inhibitors increase the risk of diabetic ketoacidosis developing in the community and during hospital admission. Journal of Clinical Endocrinology and Metabolism, 104, 3077–3087. https://doi.org/10.1210/jc.2019‐00139
Mehta, P. B., Robinson, A., Burkhardt, D., & Rushakoff, R. J. (2022). Inpatient perioperative euglycemic diabetic ketoacidosis due to sodium‐glucose cotransporter‐2 inhibitors—Lessons from a case series and strategies to decrease incidence. Endocrine Practice, 28, 884–888. https://doi.org/10.1016/j.eprac.2022.06.006
Auerbach, J. S., Gershengorn, H. B., Aljure, O. D., Lamelas, J., Patel, S. S., Ferreira, T. D., Gonzalez, L. A., & Cabrera, J. L. (2023). Postcardiac surgery euglycemic diabetic ketoacidosis in patients on sodium‐glucose cotransporter 2 inhibitors. Journal of Cardiothoracic and Vascular Anesthesia, 37, 956–963. https://doi.org/10.1053/j.jvca.2023.01.041
Rong, X., Zhu, Y., Wen, B., Liu, K., Li, X., Gou, Q., & Chen, X. (2022). Risk of hypovolemia associated with sodium‐glucose cotransporter‐2 inhibitors treatment: A meta‐analysis of randomized controlled trials. Frontiers in Cardiovascular Medicine, 9, 973129. https://doi.org/10.3389/fcvm.2022.973129
O'neil, C. A., Krauss, M. J., Bettale, J., Kessels, A., Costantinou, E., Dunagan, W. C., & Fraser, V. J. (2018). Medications and patient characteristics associated with falling in the hospital. Journal of Patient Safety, 14, 27–33. https://doi.org/10.1097/Pts.0000000000000163
Romo, K. G., & Gianchandani, R. (2024). Pros of inpatient sodium glucose cotransporter‐2 inhibitor use. Endocrine Practice, 30, 398–401. https://doi.org/10.1016/j.eprac.2024.02.004
Demidowich, A. P., Batty, K., & Zilbermint, M. (2022). Instituting a successful discharge plan for patients with type 2 diabetes: Challenges and solutions. Diabetes Spectrum, 35(4), 440–451.
Ferreira, J. P., Pimenta, J., Moura, B., Aguiar, C., & Franco, F. (2022). Use of sodium glucose co‐transporter 2 inhibitors in acute heart failure: A practical guidance. ESC Heart Failure, 9, 4344–4347. https://doi.org/10.1002/ehf2.14090
Singh, L. G., Ntelis, S., Siddiqui, T., Seliger, S. L., Sorkin, J. D., & Spanakis, E. K. (2024). Association of continued use of SGLT2 inhibitors from the ambulatory to inpatient setting with hospital outcomes in patients with diabetes: A nationwide cohort study. Diabetes Care, 47, 933–940. https://doi.org/10.2337/dc23‐1129
Kosiborod, M. N., Angermann, C. E., Collins, S. P., Teerlink, J. R., Ponikowski, P., Biegus, J., Comin‐Colet, J., Ferreira, J. P., Mentz, R. J., Nassif, M. E., Psotka, M. A., Tromp, J., Brueckmann, M., Blatchford, J. P., Salsali, A., & Voors, A. A. (2022). Effects of empagliflozin on symptoms, physical limitations, and quality of life in patients hospitalized for acute heart failure: Results from the EMPULSE trial. Circulation, 146, 279–288. https://doi.org/10.1161/CIRCULATIONAHA.122.059725
Szarek, M., Bhatt, D. L., Steg, P. G., Cannon, C. P., Leiter, L. A., Mcguire, D. K., Lewis, J. B., Riddle, M. C., Voors, A. A., Metra, M., Lund, L. H., Komajda, M., Testani, J. M., Wilcox, C. S., Ponikowski, P., Lopes, R. D., Banks, P., Tesfaye, E., Ezekowitz, J. A., … Pitt, B. (2021). Effect of sotagliflozin on total hospitalizations in patients with type 2 diabetes and worsening heart failure. Annals of Internal Medicine, 174, 1065–1072. https://doi.org/10.7326/M21‐0651
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, P., Tankova, T., Tsapas, A., & Buse, J. B. (2022). Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 45, 2753–2786. https://doi.org/10.2337/dci22‐0034
Fujino, E., Cobb, K. W., Schoenherr, J., Gouker, L., & Lund, E. (2023). Anesthesia considerations for a patient on semaglutide and delayed gastric emptying. Cureus, 15, e42153. https://doi.org/10.7759/cureus.42153
American Society of Anesthesiologists Consensus‐Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon‐Like Peptide‐1 (GLP‐1) Receptor Agonists. (2023). https://www.asahq.org/about‐asa/newsroom/news‐releases/2023/06/american‐society‐of‐anesthesiologists‐consensus‐based‐guidance‐on‐preoperative
Sen, S., Potnuru, P. P., Hernandez, N., Goehl, C., Praestholm, C., Sridhar, S., & Nwokolo, O. O. (2024). Glucagon‐like peptide‐1 receptor agonist use and residual gastric content before anesthesia. JAMA Surgery, 159, 660. https://doi.org/10.1001/jamasurg.2024.0111
Hashash, J. G., Thompson, C. C., & Wang, A. Y. (2024). AGA rapid clinical practice update on the management of patients taking GLP‐1 receptor agonists prior to endoscopy: Communication. Clinical Gastroenterology and Hepatology, 22, 705–707. https://doi.org/10.1016/j.cgh.2023.11.002
Fortmann, A. L., Spierling Bagsic, S. R., Talavera, L., Garcia, I. M., Sandoval, H., Hottinger, A., & Philis‐Tsimikas, A. (2020). Glucose as the fifth vital sign: A randomized controlled trial of continuous glucose monitoring in a non‐ICU hospital setting. Diabetes Care, 43, 2873–2877. https://doi.org/10.2337/dc20‐1016
Singh, L. G., Satyarengga, M., Marcano, I., Scott, W. H., Pinault, L. F., Feng, Z., Sorkin, J. D., Umpierrez, G. E., & Spanakis, E. K. (2020). Reducing inpatient hypoglycemia in the general wards using real‐time continuous glucose monitoring: The glucose telemetry system, a randomized clinical trial. Diabetes Care, 43, 2736–2743. https://doi.org/10.2337/dc20‐0840
Wallia, A., Prince, G., Touma, E., El Muayed, M., & Seley, J. J. (2020). Caring for hospitalized patients with diabetes mellitus, hyperglycemia, and COVID‐19: Bridging the remaining knowledge gaps. Current Diabetes Reports, 20, 77. https://doi.org/10.1007/s11892‐020‐01366‐0
Galindo, R. J., Aleppo, G., Klonoff, D. C., Spanakis, E. K., Agarwal, S., Vellanki, P., Olson, D. E., Umpierrez, G. E., Davis, G. M., & Pasquel, F. J. (2020). Implementation of continuous glucose monitoring in the hospital: Emergent considerations for remote glucose monitoring during the COVID‐19 pandemic. Journal of Diabetes Science and Technology, 14, 822–832. https://doi.org/10.1177/1932296820932903
Umpierrez, G., Rushakoff, R., Seley, J. J., Zhang, J. Y., Shang, T., Han, J., Spanakis, E. K., Alexanian, S., Drincic, A., Kulasa, K., Mendez, C. E., Tanton, D., Wallia, A., Zilbermint, M., & Klonoff, D. C. (2020). Hospital Diabetes Meeting 2020. Journal of Diabetes Science and Technology, 14, 928–944. https://doi.org/10.1177/1932296820939626
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., Stec, C., & Unger, J. (2021). American Association of Clinical Endocrinology Clinical Practice Guideline: The use of advanced technology in the management of persons with diabetes mellitus. Endocrine Practice, 27, 505–537. https://doi.org/10.1016/j.eprac.2021.04.008
Longo, R. R., & Joshi, R. (2022). The devil is in the details: Use, limitations, and implementation of continuous glucose monitoring in the inpatient setting. Diabetes Spectrum, 35, 405–419. https://doi.org/10.2337/dsi22‐0009
Donevant, S., Najmi, U., Ansari, U., Haque, W., & Zilbermint, M. (2022). Impact of digital technology on managing diabetes in the hospital. In D. Klonoff, D. Kerr, & E. Weitzman (Eds.), Diabetes digital health and telehealth (pp. 255–267). Elsevier.
Espinoza, J., Xu, N. Y., Nguyen, K. T., & Klonoff, D. C. (2023). The need for data standards and implementation policies to integrate CGM data into the electronic health record. Journal of Diabetes Science and Technology, 17, 495–502. https://doi.org/10.1177/19322968211058148
Aleppo, G., Chmiel, R., Zurn, A., Bandoske, R., Creamer, P., Neubauer, N., Wong, J., Andrade, S. B., & Hauptman, A. (2023). Integration of continuous glucose monitoring data into an electronic health record system: Single‐center implementation. Journal of Diabetes Science and Technology, https://doi.org/10.1177/19322968231196168
Mandel, S. R., Langan, S., Mathioudakis, N. N., Sidhaye, A. R., Bashura, H., Bie, J. Y., Mackay, P., Tucker, C., Demidowich, A. P., Simonds, W. F., Jha, S., Ebenuwa, I., Kantsiper, M., Howell, E. E., Wachter, P., Golden, S. H., & Zilbermint, M. (2019). Retrospective study of inpatient diabetes management service, length of stay and 30‐day readmission rate of patients with diabetes at a community hospital. Journal of Community Hospital Internal Medicine Perspectives, 9, 64–73. https://doi.org/10.1080/20009666.2019.1593782
Newton, C. A., & Young, S. (2006). Financial implications of glycemic control: Results of an inpatient diabetes management program. Endocrine Practice, 12, 43–48. https://doi.org/10.4158/EP.12.S3.43
Koproski, J., Pretto, Z., & Poretsky, L. (1997). Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care, 20, 1553–1555. https://doi.org/10.2337/diacare.20.10.1553
Drincic, A. T., Akkireddy, P., & Knezevich, J. T. (2018). Common models used for inpatient diabetes management. Current Diabetes Reports, 18, 10. https://doi.org/10.1007/s11892‐018‐0972‐x
Simmons, D., Hartnell, S., Watts, J., Ward, C., Davenport, K., Gunn, E., & Jenaway, A. (2015). Effectiveness of a multidisciplinary team approach to the prevention of readmission for acute glycaemic events. Diabetic Medicine, 32, 1361–1367. https://doi.org/10.1111/dme.12779
Shelton, C., Demidowich, A. P., Motevalli, M., Sokolinsky, S., Mackay, P., Tucker, C., Abundo, C., Peters, E., Gooding, R., Hackett, M., Wedler, J., Alexander, L. A., Barry, L., Flynn, M., Rios, P., Fulda, C. L., Young, M. F., Kahl, B., Pummer, E., … Zilbermint, M. (2021). Retrospective quality improvement study of insulin‐induced hypoglycemia and implementation of hospital‐wide initiatives. Journal of Diabetes Science and Technology, 15, 733–740. https://doi.org/10.1177/19322968211008513
Demidowich, A. P., Batty, K., Love, T., Sokolinsky, S., Grubb, L., Miller, C., Raymond, L., Nazarian, J., Ahmed, M. S., Rotello, L., & Zilbermint, M. (2021). Effects of a dedicated inpatient diabetes management service on glycemic control in a community hospital setting. Journal of Diabetes Science and Technology, 15, 546–552. https://doi.org/10.1177/1932296821993198
Zilbermint, M. (2021). The endocrine hospitalist: Enhancing the quality of diabetes care. Journal of Diabetes Science and Technology, 15, 762–767. https://doi.org/10.1177/19322968211007908
Najmi, U., Haque, W. Z., Ansari, U., Yemane, E., Alexander, L. A., Lee, C., Demidowich, A. P., Motevalli, M., Mackay, P., Tucker, C., Notobartolo, C., Sartippour, P., Raynor, J., & Zilbermint, M. (2021). Inpatient insulin pen implementation, waste, and potential cost savings: A community hospital experience. Journal of Diabetes Science and Technology, 15, 741–747. https://doi.org/10.1177/19322968211002514
Khan, S. A., Demidowich, A. P., Tschudy, M. M., Wedler, J., Lamy, W., Akpandak, I., Alexander, L. A., Misra, I., Sidhaye, A., Rotello, L., & Zilbermint, M. (2023). Increasing frequency of hemoglobin A1C measurements in hospitalized patients with diabetes: A quality improvement project using Lean Six Sigma. Journal of Diabetes Science and Technology, 18, 866. https://doi.org/10.1177/19322968231153883
Batty, K., Pugh, P., Schwartzbauer, A., Carvalho, T., & Demidowich, A. P. (2023). Diabetes‐related gastroparesis in the acute care setting: A case report. AACN Advanced Critical Care, 34, 47–52. https://doi.org/10.4037/aacnacc2023730
Haque, W. Z., Demidowich, A. P., Sidhaye, A., Golden, S. H., & Zilbermint, M. (2021). The financial impact of an inpatient diabetes management service. Current Diabetes Reports, 21, 5. https://doi.org/10.1007/s11892‐020‐01374‐0
Menzin, J., Korn, J. R., Cohen, J., Lobo, F., Zhang, B., Friedman, M., & Newmann, P. J. (2010). Relationship between glycemic control and diabetes‐related hospital costs in patients with type 1 or type 2 diabetes mellitus. Journal of Managed Care & Specialty Pharmacy, 16, 264–275. https://doi.org/10.18553/jmcp.2010.16.4.264
CMS. (2024). https://www.cms.gov/newsroom/fact‐sheets/fy‐2025‐hospital‐inpatient‐prospective‐payment‐system‐ipps‐and‐long‐term‐care‐hospital‐prospective
Umpierrez, G., & Korytkowski, M. (2016). Diabetic emergencies — Ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nature Reviews Endocrinology, 12, 222–232. https://doi.org/10.1038/nrendo.2016.15
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020). Diabetic ketoacidosis. Nature Reviews Disease Primers, 6, 1–20. https://doi.org/10.1038/s41572‐020‐0165‐1
Pyle, L., Bergman, B. C., Nadeau, K. J., & Cree‐Green, M. (2016). Modeling changes in glucose and glycerol rates of appearance when true basal rates of appearance cannot be readily determined. American Journal of Physiology‐Endocrinology and Metabolism, 310, E323–E331. https://doi.org/10.1152/ajpendo.00368.2015
Pasquel, F. J., Tsegka, K., Wang, H., Cardona, S., Galindo, R. J., Fayfman, M., Davis, G., Vellanki, P., Migdal, A., Gujral, U., Narayan, K. M. V., & Umpierrez, G. E. (2019). Clinical outcomes in patients with isolated or combined diabetic ketoacidosis and hyperosmolar hyperglycemic state: A retrospective, hospital‐based cohort study. Diabetes Care, 43, 349–357. https://doi.org/10.2337/dc19‐1168
Balasubramanyam, A., Zern, J. W., Hyman, D. J., & Pavlik, V. (1999). New profiles of diabetic ketoacidosis: Type 1 vs type 2 diabetes and the effect of ethnicity. Archives of Internal Medicine, 159, 2317–2322. https://doi.org/10.1001/archinte.159.19.2317
Davis, T. M. E., & Davis, W. (2020). Incidence and associates of diabetic ketoacidosis in a community‐based cohort: The Fremantle Diabetes Study Phase II. BMJ Open Diabetes Research and Care, 8, e000983. https://doi.org/10.1136/bmjdrc‐2019‐000983
Dhatariya, K. K., & Joint British Diabetes Societies for Inpatient Care. (2022). The management of diabetic ketoacidosis in adults—An updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabetic Medicine, 39, e14788. https://doi.org/10.1111/dme.14788
Reinhart, K., Perner, A., Sprung, C. L., Jaeschke, R., Schortgen, F., Johan Groeneveld, A. B., Beale, R., & Hartog, C. S. (2012). Consensus statement of the ESICM Task Force on colloid volume therapy in critically ill patients. Intensive Care Medicine, 38, 368–383. https://doi.org/10.1007/s00134‐012‐2472‐9
Self, W. H., Evans, C. S., Jenkins, C. A., Brown, R. M., Casey, J. D., Collins, S. P., Coston, T. D., Felbinger, M., Flemmons, L. N., Hellervik, S. M., Lindsell, C. J., Liu, D., Mccoin, N. S., Niswender, K. D., Slovis, C. M., Stollings, J. L., Wang, L., Rice, T. W., & Semler, M. W. (2020). Clinical effects of balanced crystalloids vs saline in adults with diabetic ketoacidosis: A subgroup analysis of cluster randomized clinical trials. JAMA Network Open, 3, e2024596. https://doi.org/10.1001/jamanetworkopen.2020.24596
Tamzil, R., Yaacob, N., Noor, N., & Baharuddin, K. (2023). Comparing the clinical effects of balanced electrolyte solutions versus normal saline in managing diabetic ketoacidosis: A systematic review and meta‐analyses. Turkish Journal of Emergency Medicine, 23, 131. https://doi.org/10.4103/tjem.tjem_355_22
Jahangir, A., Jahangir, A., Siddiqui, F. S., Niazi, M. R. K., Yousaf, F., Muhammad, M., Sahra, S., Javed, A., Sharif, M. A., Iqbal, Q. Z., & Krzyzak, M. (2022). Normal saline versus low chloride solutions in treatment of diabetic ketoacidosis: A systematic review of clinical trials. Cureus, 14(1), e21324. https://doi.org/10.7759/cureus.21324
Vallée, M., Barthélémy, I., Friciu, M., Pelletier, É., Forest, J. M., Benoit, F., & Leclair, G. (2021). Compatibility of lactated ringer's injection with 94 selected intravenous drugs during simulated Y‐site administration. Hospital Pharmacy, 56, 228–234. https://doi.org/10.1177/0018578719888913
Buckley, C. T., Farrar, J. E., Schleicher, M., Stollings, J. L., Duggal, A., & Bauer, S. R. (2024). Physical and chemical compatibility of medications commonly used in critically ill patients with balanced crystalloids: A systematic review. Annals of Pharmacotherapy, 58, 322–332. https://doi.org/10.1177/10600280231179999
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009). Hyperglycemic crises in adult patients with diabetes. Diabetes Care, 32, 1335–1343. https://doi.org/10.2337/dc09‐9032
Umpierrez, G. E. (2020). Hyperglycemic crises: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. In E. Bonora & R. DeFronzo (Eds.), Diabetes complications, comorbidities and related disorders. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-030-36694-0_21
Green, S. M., Rothrock, S. G., Ho, J. D., Gallant, R. D., Borger, R., Thomas, T. L., & Zimmerman, G. J. (1998). Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Annals of Emergency Medicine, 31, 41–48. https://doi.org/10.1016/s0196‐0644(98)70279‐3
Viallon, A., Zeni, F., Lafond, P., Venet, C., Tardy, B., Page, Y., & Bertrand, J. C. (1999). Does bicarbonate therapy improve the management of severe diabetic ketoacidosis? Critical Care Medicine, 27, 2690–2693. https://doi.org/10.1097/00003246‐199912000‐00014
Duhon, B., Attridge, R. L., Franco‐Martinez, A. C., Maxwell, P. R., & Hughes, D. W. (2013). Intravenous sodium bicarbonate therapy in severely acidotic diabetic ketoacidosis. Annals of Pharmacotherapy, 47, 970–975. https://doi.org/10.1345/aph.1S014
Chua, H. R., Schneider, A., & Bellomo, R. (2011). Bicarbonate in diabetic ketoacidosis—A systematic review. Annals of Intensive Care, 1, 23. https://doi.org/10.1186/2110‐5820‐1‐23
Udensi, U., & Tchounwou, P. (2017). Potassium homeostasis, oxidative stress, and human disease. International Journal of Clinical and Experimental Ophthalmology, 4, 111–122. https://doi.org/10.4103/ijcep.ijcep_43_17
Goyal, N., Miller, J. B., Sankey, S. S., & Mossallam, U. (2010). Utility of initial bolus insulin in the treatment of diabetic ketoacidosis. Journal of Emergency Medicine, 38, 422–427. https://doi.org/10.1016/j.jemermed.2007.11.033
Brown, H., Tran, R., & Patka, J. (2018). Effect of bolus insulin administration followed by a continuous insulin infusion on diabetic ketoacidosis management. Pharmacy, 6, 129. https://doi.org/10.3390/pharmacy6040129
Jouini, S., Hebaieb, F., Hamed, R., Hedhli, H., Manai, H., Chermiti, I., Jendoubi, A., Maaref, A., Jebali, A., Zoubli, A., & Bouhajja, B. (2019). Utility of bolus of insulin in diabetic ketoacidosis management in emergency department. Journal of Anesthesia, 8, 1–6.
Umpierrez, G. E., Cuervo, R., Karabell, A., Latif, K., Freire, A. X., & Kitabchi, A. E. (2004). Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care, 27, 1873–1878. https://doi.org/10.2337/diacare.27.8.1873
Rao, P., Jiang, S. F., Kipnis, P., Patel, D. M., Katsnelson, S., Madani, S., & Liu, V. X. (2022). Evaluation of outcomes following hospital‐wide implementation of a subcutaneous insulin protocol for diabetic ketoacidosis. JAMA Network Open, 5, e226417. https://doi.org/10.1001/jamanetworkopen.2022.6417
Sell, J., Haas, N. L., Korley, F. K., Cranford, J. A., & Bassin, B. S. (2023). Euglycemic diabetic ketoacidosis: Experience with 44 patients and comparison to hyperglycemic diabetic ketoacidosis. Western Journal of Emergency Medicine, 24, 1049–1055. https://doi.org/10.5811/westjem.60361
Umapathysivam, M. M., Morgan, B., Inglis, J. M., Meyer, E., Liew, D., Thiruvenkatarajan, V., & Jesudason, D. (2024). SGLT2 inhibitor–associated ketoacidosis vs type 1 diabetes–associated ketoacidosis. JAMA Network Open, 7, e242744. https://doi.org/10.1001/jamanetworkopen.2024.2744
Mohamed, A., Ploetz, J., & Hamarshi, M. S. (2021). https://www.ingentaconnect.com/content/ben/cdr/2021/00000017/00000008/art00005. https://doi.org/10.2174/1573399817666210303095633
Thammakosol, K., & Sriphrapradang, C. (2023). Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial. Diabetes, Obesity and Metabolism, 25, 815–822. https://doi.org/10.1111/dom.14929
Doshi, P., Potter, A. J., De Los Santos, D., Banuelos, R., Darger, B. F., & Chathampally, Y. (2015). Prospective randomized trial of insulin glargine in acute management of diabetic ketoacidosis in the emergency department: A pilot study. Academic Emergency Medicine, 22, 657–662. https://doi.org/10.1111/acem.12673
Murray, D. S., Gilbert, B. W., & Cox, T. R. (2024). Pilot study on the impact of early subcutaneous basal insulin administration in diabetic ketoacidosis. Journal of Intensive Care Medicine, https://doi.org/10.1177/08850666241247516
Pratumvinit, B., Lam, L., Kongruttanachok, N., Hemthong, C., Kost, G. J., Kamkang, P., & Reesukumal, K. (2020). Anion gap reference intervals show instrument dependence and weak correlation with albumin levels. Clinica Chimica Acta, 500, 172–179. https://doi.org/10.1016/j.cca.2019.10.012
Feldman, M., Soni, N., & Dickson, B. (2005). Influence of hypoalbuminemia or hyperalbuminemia on the serum anion gap. Journal of Laboratory and Clinical Medicine, 146, 317–320. https://doi.org/10.1016/j.lab.2005.07.008
Kraut, J. A., & Madias, N. E. (2007). Serum anion gap: Its uses and limitations in clinical medicine. Clinical Journal of the American Society of Nephrology, 2, 162. https://doi.org/10.2215/CJN.03020906
Haas, N. L., Sell, J., Cranford, J. A., Korley, F. K., & Bassin, B. S. (2023). The two‐bag method for management of adult diabetic ketoacidosis—Experience with 634 patients. Journal of Intensive Care Medicine, 38, 668–674. https://doi.org/10.1177/08850666231175387
Munir, I., Fargo, R., Garrison, R., Yang, A., Cheng, A., Kang, I., Motabar, A., Xu, K., Loo, L. K., & Kim, D. I. (2017). Comparison of a ‘two‐bag system’ versus conventional treatment protocol (‘one‐bag system’) in the management of diabetic ketoacidosis. Health Services Research, 5(1), e000395.
Cho, N., Bushell, T., Choi, M., & Moussavi, K. (2021). Evaluation of the two‐bag system in adult diabetic ketoacidosis patients. Journal of Pharmacy Practice, 34, 17–22. https://doi.org/10.1177/0897190019855163
Yuan, X., Wang, J., Chen, X., Yan, W., Niu, Q., Tang, N., Zhang, M. Z., Gu, W., & Wang, X. (2022). Effects of the timing of the initiation of dietary intake on pediatric type 1 diabetes for diabetic ketoacidosis. BMC Pediatrics [Electronic Resource], 22, 206. https://doi.org/10.1186/s12887‐022‐03243‐z
Lipatov, K., Kurian, K. K., Shaver, C., White, H. D., Ghamande, S., Arroliga, A. C., & Surani, S. (2019). Early vs late oral nutrition in patients with diabetic ketoacidosis admitted to a medical intensive care unit. World Journal of Diabetes, 10, 57–62. https://doi.org/10.4239/wjd.v10.i1.57
Ruszala, V. (2019). Ensuring continuity of care for patients with diabetes mellitus. Nursing Standard, 35, 61–66. https://doi.org/10.7748/ns.2019.e11454
Skriver, L. K. L., Nielsen, M. W., Walther, S., Nørlev, J. D., & Hangaard, S. (2023). Factors associated with adherence or nonadherence to insulin therapy among adults with type 2 diabetes mellitus: A scoping review. Journal of Diabetes and Its Complications, 37, 108596. https://doi.org/10.1016/j.jdiacomp.2023.108596
Castellana, M., Cignarelli, A., Brescia, F., Laviola, L., & Giorgino, F. (2019). GLP‐1 receptor agonist added to insulin versus basal‐plus or basal‐bolus insulin therapy in type 2 diabetes: A systematic review and meta‐analysis. Diabetes/Metabolism Research and Reviews, 35, e3082. https://doi.org/10.1002/dmrr.3082
Giugliano, D., Longo, M., Caruso, P., Di Fraia, R., Scappaticcio, L., Gicchino, M., Petrizzo, M., Bellastella, G., Maiorino, M. I., & Esposito, K. (2021). Feasibility of simplification from a basal‐bolus insulin regimen to a fixed‐ratio formulation of basal insulin plus a GLP‐1RA or to basal insulin plus an SGLT2 inhibitor: BEYOND, a randomized, pragmatic trial. Diabetes Care, 44, 1353–1360. https://doi.org/10.2337/dc20‐2623
Giugliano, D., Chiodini, P., Maiorino, M. I., Bellastella, G., & Esposito, K. (2016). Intensification of insulin therapy with basal‐bolus or premixed insulin regimens in type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials. Endocrine, 51, 417–428. https://doi.org/10.1007/s12020‐015‐0718‐3
Abdul‐Ghani, M. A., Puckett, C., Triplitt, C., Maggs, D., Adams, J., Cersosimo, E., & DeFronzo, R. A. (2015). Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add‐on therapy in subjects with new‐onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): A randomized trial. Diabetes, Obesity & Metabolism, 17, 268–275. https://doi.org/10.1111/dom.12417
Phung, O. J., Sobieraj, D. M., Engel, S. S., & Rajpathak, S. N. (2014). Early combination therapy for the treatment of type 2 diabetes mellitus: Systematic review and meta‐analysis. Diabetes, Obesity & Metabolism, 16, 410–417. https://doi.org/10.1111/dom.12233
Nagel, K. E., Ramachandran, R., & Lipska, K. J. (2024). Lessons from insulin: Policy prescriptions for affordable diabetes and obesity medications. Diabetes Care. https://doi.org/10.2337/dci23-0042
Montejano, L., Vo, L., & Mcmorrow, D. (2016). Transitions of care for people with type 2 diabetes: Utilization of antihyperglycemic agents pre‐ and post‐hospitalization. Diabetes Therapy, 7, 91–103. https://doi.org/10.1007/s13300‐015‐0148‐5
Shlomowitz, A., & Feher, M. D. (2014). Anxiety associated with self monitoring of capillary blood glucose. British Journal of Diabetes, 14, 60–63. https://doi.org/10.15277/bjdvd.2014.018
Burge, M. R. (2001). Lack of compliance with home blood glucose monitoring predicts hospitalization in diabetes. Diabetes Care, 24, 1502–1503. https://doi.org/10.2337/diacare.24.8.1502
Karter, A. J., Parker, M. M., Moffet, H. H., Gilliam, L. K., & Dlott, R. (2021). Association of real‐time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin‐treated diabetes. JAMA, 325, 2273–2284. https://doi.org/10.1001/jama.2021.6530
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop‐Busui, R., Philis‐Tsimikas, A., Bao, S., Umpierrez, G., Davis, G., Kruger, D., Bhargava, A., Young, L., Mcgill, J. B., Aleppo, G., Nguyen, Q. T., Orozco, I., Biggs, W., … Balo, A. (2021). Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: A randomized clinical trial. JAMA, 325, 2262–2272. https://doi.org/10.1001/jama.2021.7444
Al Hayek, A. A., Robert, A. A., & Al Dawish, M. A. (2017). Evaluation of FreeStyle Libre flash glucose monitoring system on glycemic control, health‐related quality of life, and fear of hypoglycemia in patients with type 1 diabetes. Clinical Medicine Insights: Endocrinology and Diabetes, 10, 1179551417746957. https://doi.org/10.1177/1179551417746957
O'connor, M. J., Ding, X., Hernandez, C., Hubacz, L., Church, R. J., & O'connor, L. (2024). A pilot trial of continuous glucose monitoring upon emergency department discharge among people with diabetes mellitus. Endocrine Practice, 30, 122–127. https://doi.org/10.1016/j.eprac.2023.11.001
Barnett, A., Chiruvella, V., Elshimy, G., Grimm, J., & Healy, S. (2022). PSUN229 transitions of care and readmissions in patients with diabetes receiving CGM at hospital discharge. Journal of the Endocrine Society, 6, A384–A385. https://doi.org/10.1210/jendso/bvac150.800
Healy, S. J., Black, D., Harris, C., Lorenz, A., & Dungan, K. M. (2013). Inpatient diabetes education is associated with less frequent hospital readmission among patients with poor glycemic control. Diabetes Care, 36, 2960–2967. https://doi.org/10.2337/dc13‐0108
Leinung, M. C., Gianoukakis, A. G., Lee, D. W., Jeronis, S. L., & Desemone, J. (2000). Comparison of diabetes care provided by an endocrinology clinic and a primary‐care clinic. Endocrine Practice, 6, 361–366. https://doi.org/10.4158/EP.6.5.361
Van Dam, H. A., Van Der Horst, F. G., Knoops, L., Ryckman, R. M., Crebolder, H. F. J. M., & Van Den Borne, B. H. W. (2005). Social support in diabetes: A systematic review of controlled intervention studies. Patient Education and Counseling, 59, 1–12. https://doi.org/10.1016/j.pec.2004.11.001
Strom, J. L., & Egede, L. E. (2012). The impact of social support on outcomes in adult patients with type 2 diabetes: A systematic review. Current Diabetes Reports, 12, 769–781. https://doi.org/10.1007/s11892‐012‐0317‐0